Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Lunai Bioworks Inc (RENB)

Lunai Bioworks Inc (RENB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 230,594
  • Shares Outstanding, K 162,390
  • Annual Sales, $ 0 K
  • Annual Income, $ -80,650 K
  • EBIT $ -20 M
  • EBITDA $ 35 M
  • 60-Month Beta 0.54
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.23
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.50
  • Most Recent Earnings $0.00 on 05/15/25
  • Next Earnings Date 10/09/25
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical Information Systems

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.1300 +25.66%
on 09/30/25
2.4500 -42.04%
on 09/02/25
-0.9600 (-40.34%)
since 08/29/25
3-Month
1.1300 +25.66%
on 09/30/25
3.6000 -60.56%
on 07/17/25
-1.4690 (-50.85%)
since 06/30/25
52-Week
1.1300 +25.66%
on 09/30/25
21.0000 -93.24%
on 12/09/24
-3.4130 (-70.62%)
since 09/30/24

Most Recent Stories

More News
Lunai Bioworks: Fiscal Q1 Earnings Snapshot

Lunai Bioworks: Fiscal Q1 Earnings Snapshot

RENB : 1.4200 (+12.16%)
Lunai Bioworks Inc. Unveils Transformer Platform to Secure Generative AI and Accelerate Drug Discovery

Proprietary safety intelligence creates dual value: faster therapeutic development and biodefense.

RENB : 1.4200 (+12.16%)
AI Just Got a Green Light from the White House--Here's What That Means for Healthcare Stocks

Equity Insider News Commentary Issued on behalf of Avant Technologies Inc.

TREN : 1.4000 (-1.41%)
HCTI : 2.30 (+3.60%)
RENB : 1.4200 (+12.16%)
AVAI : 0.2951 (-1.63%)
GEHC : 82.52 (-1.28%)
MDAI : 1.6900 (+3.68%)
AI Just Got a Green Light from the White House--Here's What That Means for Healthcare Stocks

/CNW/ -- Equity Insider News Commentary – There's a lot of big voices pushing for the AI revolution to make its mark, including a new plan from the U.S....

RENB : 1.4200 (+12.16%)
HCTI : 2.30 (+3.60%)
AVAI : 0.2951 (-1.63%)
GEHC : 82.52 (-1.28%)
MDAI : 1.6900 (+3.68%)
ACN : 269.34 (-1.29%)
Renovaro Secures Key AI Patents, Strengthening Market Position in $20B Biomedical AI Sector

Strategic IP expansion protects federated learning technology driving pharma partnerships, biosecurity initiatives, and precision medicine growth

RENB : 1.4200 (+12.16%)
Smart Healthcare Is Taking Over. Here's Where the Money's Headed

/CNW/ -- Both politicians and leaders in academia are touting the AI revolution empowering the frontline of what's dubbed Smart Healthcare. In a recent...

RENB : 1.4200 (+12.16%)
GOOG : 318.39 (-0.70%)
GOOGL : 317.62 (-0.63%)
AVAI : 0.2951 (-1.63%)
AMZN : 229.11 (-1.41%)
OMDA : 17.39 (+7.81%)
Renovaro Secures Key U.S. Patent to Strengthen AI-Driven Drug Discovery and Diagnostics Platform

RENB : 1.4200 (+12.16%)
AI Could Add $461 Billion to Global Healthcare--And These New Platforms Are Leading the Charge

/CNW/ -- Equity Insider News Commentary – A new report from Philips reveals a growing divide between doctors and patients when it comes to AI in healthcare....

MSFT : 480.84 (+0.65%)
RENB : 1.4200 (+12.16%)
AVAI : 0.2951 (-1.63%)
CCLD : 3.14 (+1.95%)
CERT : 9.57 (-1.14%)
ACN : 269.34 (-1.29%)
UPDATE - Renovaro Inc. Announces Expedited Trial for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology

RENB : 1.4200 (+12.16%)
POAI : 5.47 (-0.64%)
Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology

RENB : 1.4200 (+12.16%)
POAI : 5.47 (-0.64%)

Business Summary

Lunai Bioworks Inc. is an AI-powered drug discovery and biodefense company. Lunai Bioworks Inc., formerly known as RENOVARO INC, is based in LOS ANGELES.

See More

Key Turning Points

3rd Resistance Point 1.8233
2nd Resistance Point 1.6267
1st Resistance Point 1.5233
Last Price 1.4200
1st Support Level 1.2233
2nd Support Level 1.0267
3rd Support Level 0.9233

See More

52-Week High 21.0000
Fibonacci 61.8% 13.4097
Fibonacci 50% 11.0650
Fibonacci 38.2% 8.7203
Last Price 1.4200
52-Week Low 1.1300

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar